Who Paid My Doc
Usman Siddiqui
Clinical Cardiac Electrophysiology Winter Park, FL Medical Doctor
NPI 1467623199 CMS profile 66958
483 N Semoran Blvd, Suite 102, Winter Park, FL 32792
General payments
$1,233,914
Research payments
$925
Ownership & investment interest
$24,864
Research they led as principal investigator
$2,322,939
Through program year 2025, Usman Siddiqui of Winter Park, FL is reported in the CMS Open Payments database as having received $1,233,914 across 2,276 general payments and $925 in research payments paid to them. Separately, studies naming them as principal investigator received $2,322,939 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $24,864 across 1 holding.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $253,175 | 346 | |
| 2024 | General | $219,879 | 393 | |
| 2024 | Research | $875 | 1 | |
| 2023 | General | $166,728 | 341 | |
| 2022 | General | $139,205 | 266 | |
| 2021 | General | $132,400 | 235 | |
| 2020 | General | $143,300 | 232 | |
| 2020 | Research | $50 | 2 | |
| 2019 | General | $179,228 | 463 | |
| 2025 | Ownership | $24,864 | 1 |
Beside peers
- Usman Siddiqui
- Clinical Cardiac Electrophysiology median
- Middle half of Clinical Cardiac Electrophysiology
- National median
In program year 2025, general payments to Usman Siddiqui were reported at $253,175. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.
Show as a table
| Year | Usman Siddiqui | Clinical Cardiac Electrophysiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $179,228 | $2,361 | $585–$8,260 | $163 |
| 2020 | $143,300 | $993 | $247–$4,351 | $114 |
| 2021 | $132,400 | $1,185 | $326–$4,739 | $132 |
| 2022 | $139,205 | $2,073 | $554–$6,789 | $149 |
| 2023 | $166,728 | $2,568 | $759–$8,159 | $160 |
| 2024 | $219,879 | $2,557 | $703–$7,403 | $164 |
| 2025 | $253,175 | $2,462 | $733–$7,710 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 35 drugsPart D claims
2,231
Drug cost
$639,998
Branded share of claims
39.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 298 | $303,350 | |
| Entresto Sacubitril/Valsartan | Brand | 97 | $137,851 | |
| Xarelto Rivaroxaban | Brand | 95 | $100,079 | |
| Farxiga Dapagliflozin Propanediol | Brand | 29 | $34,241 | |
| Jardiance Empagliflozin | Brand | 15 | $19,664 | |
| Dofetilide | Generic | 58 | $14,003 | |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | Brand | 27 | $10,489 | |
| Metoprolol Succinate | Generic | 270 | $3,966 | |
| Sotalol Sotalol Hcl | Brand | 172 | $3,889 | |
| Amiodarone Hcl | Generic | 72 | $1,573 |
The 10 drugs with the highest cost, of 35 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 126 billing codesPaid by Medicare
$1,113,898
Medicare patients
803
Services billed
8,322
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 75% | |
| Atrial fibrillation | 72% | |
| Diabetes | 53% | |
| Heart failure | 52% | |
| Arthritis | 50% | |
| Chronic kidney disease | 45% | |
| COPD | 29% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 22 | 1,725 | $185 |
| Injection, midazolam hydrochloride, per 1 mg J2250 | Office | 22 | 29 | $3 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
First 5 of 6 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| CAMZYOS |
|
$4,250 | — | — |
| LEQVIO |
|
$66 | — | — |
| ENTRESTO |
|
$44 | 97 | — |
| FARXIGA |
|
$36 | 29 | — |
| VERQUVO |
|
$20 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 6 in the dashboard with a free accountRecords
2,279 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Cardiac Electrophysiology in Florida
Jose Osorio Filho
Clinical Cardiac Electrophysiology · Miami, FL
David Kenigsberg
Clinical Cardiac Electrophysiology · Fort Lauderdale, FL
Raul Weiss
Clinical Cardiac Electrophysiology · Miami Beach, FL
Naushad Shaik
Clinical Cardiac Electrophysiology · Kissimmee, FL
Parikshit Sharma
Clinical Cardiac Electrophysiology · Weston, FL
Saumil Oza
Clinical Cardiac Electrophysiology · Jacksonville, FL
Related records
Clinical Cardiac Electrophysiology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Cardiac Electrophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.